These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 4791)

  • 1. Comparison of short-term treatment regimens in phobic patients: a preliminary report.
    Zitrin CM; Klein DF; Lindemann C; Tobak P; Rock M; Kaplan JE; Ganz VH
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):233-50. PubMed ID: 4791
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavior therapy, supportive psychotherapy, imipramine, and phobias.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1978 Mar; 35(3):307-16. PubMed ID: 31847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
    Zitrin CM; Klein DF; Woerner MG; Ross DC
    Arch Gen Psychiatry; 1983 Feb; 40(2):125-38. PubMed ID: 6337578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically significant improvement in agoraphobia research.
    Mavissakalian M
    Behav Res Ther; 1986; 24(3):369-70. PubMed ID: 2873811
    [No Abstract]   [Full Text] [Related]  

  • 6. Imipramine, behavior therapy, and phobia.
    Zitrin CM; Klein DF
    Psychopharmacol Bull; 1975 Oct; 11(4):41-2. PubMed ID: 1105642
    [No Abstract]   [Full Text] [Related]  

  • 7. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
    Marks IM; Gray S; Cohen D; Hill R; Mawson D; Ramm E; Stern RS
    Arch Gen Psychiatry; 1983 Feb; 40(2):153-62. PubMed ID: 6130752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pharmacological and behavioral treatment for agoraphobia.
    Telch MJ; Agras WS; Taylor CB; Roth WT; Gallen CC
    Behav Res Ther; 1985; 23(3):325-35. PubMed ID: 2860892
    [No Abstract]   [Full Text] [Related]  

  • 11. Agoraphobia: indications for the application of the multimodal behavioral conceptualization.
    Popler K
    J Nerv Ment Dis; 1977 Feb; 164(2):97-101. PubMed ID: 13149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. School phobia: diagnostic considerations in the light of imipramine effects.
    Gittelman-Klein R; Klein DF
    J Nerv Ment Dis; 1973 Mar; 156(3):199-215. PubMed ID: 4698665
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
    Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
    J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief behavior therapy with an elderly patient. a case study.
    Garfinkel R
    J Geriatr Psychiatry; 1979; 12(1):101-9. PubMed ID: 45443
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaginal flooding and exposure to real phobic situations: treatment outcome with agoraphobic patients.
    Mathews AM; Johnston DW; Lancashire M; Munby M; Shaw PM; Gelder MG
    Br J Psychiatry; 1976 Oct; 129():361-71. PubMed ID: 10036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behaviour therapy in phobic and obsessional disorders.
    Cobb J
    Psychiatr Dev; 1983; 1(4):351-65. PubMed ID: 6144099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agoraphobia: a review for the physician.
    Vale WH; Mlott SR
    South Med J; 1980 Dec; 73(12):1607-10. PubMed ID: 6108614
    [No Abstract]   [Full Text] [Related]  

  • 20. The placebo effect in agoraphobia.
    Mavissakalian M
    J Nerv Ment Dis; 1987 Feb; 175(2):95-9. PubMed ID: 2879882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.